This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Non-falciparum malaria

  • Malaria caused by P. ovale, P. vivax and P. malariae can be treated in an/on outpatient basis (except in instances where the patient has other co-morbidities)
  • Haemoglobin concentration should be measured
  • glucose-6-phosphate dehydrogenase (G6PD) activity should be measured in patients with vivax or ovale since primaquinine therapy is needed to eliminate hypnozoites (dormant forms) from the liver
  • patients with mixed infection (which includes falciparum parasites) and with an infection that cannot be speciated treatment should follow falciparum management

Falciparum malaria

  • all patients with falciparum malaria infections should initially be admitted to the hospital
  • due to the possibility of rapid progression and poor tolerance of oral therapies children also should be admitted to the hospital for at least 24 hours
  • pregnant women, infants and the elderly should be monitored closely since they have an increased risk of developing severe disease or to deteriorate rapidly
  • specialist advice should be sought in management of severe falciparum malaria (1)

Treatment alternatives are dependent on whether the patient has a severe (complicated) infection (with P. falciparum or other species), or the patient has an uncomplicated mild infection.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.